Manuela Ferracin
Bologna, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 157 publications
Exploring the Role of TERT Promoter Mutations in Advanced Melanoma Treated With BRAF/MEK Inhibitors or Immune Checkpoint Inhibitors.
Journal: Anticancer research
Published: May 12, 2026
Circulating tumor cells as biomarkers in melanoma: techniques, challenges, and clinical applications.
Journal: Frontiers in cell and developmental biology
Published: April 16, 2026
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma.
Journal: Cells
Published: March 10, 2026
Targeting HGF/MET and CXCL1/CXCR2 axes bypasses resistance to KRASG12C inhibitors in NSCLC.
Journal: Lung cancer (Amsterdam, Netherlands)
Published: November 13, 2025
Quantification of Tissue and Circulating MicroRNAs by Droplet Digital PCR.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: October 10, 2025
Profibrotic Molecules Are Reduced in CRISPR-Edited Emery-Dreifuss Muscular Dystrophy Fibroblasts.
Journal: Cells
Published: July 18, 2025
Merkel Cell Carcinoma: An Updated Review Focused on Bone and Bone Marrow Metastases.
Journal: Cancers
Published: April 02, 2025
Predictive Factors for Sentinel Lymph Node Positivity in Melanoma Patients-The Role of Liquid Biopsy, MicroRNA and Gene Expression Profile Panels.
Journal: Cancers
Published: March 06, 2025
Vaccine-Based Immunotherapy for Oropharyngeal and Nasopharyngeal Cancers.
Journal: Journal of clinical medicine
Published: December 15, 2024
The 2024 Nobel Prize in Physiology or Medicine: microRNA Takes Center Stage.
Journal: Non-coding RNA
Published: December 02, 2024
Circulating MicroRNAs in Patients with Psoriasis Treated with Anti-IL-23: A Cohort Study.
Journal: Dermatology and therapy
Published: October 10, 2024
Last Updated: 09/26/2026